Agenda - Council Work Session - 04/11/2023

Home

HF100 NINTH ENGROSSMENT REVISOR BD 1-10100-9 112.1 which the change becomes effective. In this notification, the office must specify the proposed 112.2 addition or modification, the reasons for the addition or modification, any written comments 112.3 received by the office from the public about the addition or modification, and any guidance 112.4 received from the Cannabis Advisory Council. An addition or modification by the office 112.5 under this subdivision becomes effective on August 1 of that year unless the legislature by 112.6 law provides otherwise. 112.7 EFFECTIVE DATE. This section is effective January 1, 2024. 112.8 Sec. 54. [342.541 DUTIES OF DIVISION OF MEDICAL CANNABIS; REGISTRY 112.9 PROGRAM. 112.10 Subdivision 1. Duties related to health care practitioners. The Division of Medical 112.11 Cannabis must: 112.12 (1) provide notice of the registry program to health care practitioners in the state; 112.13 (2) allow health care practitioners to participate in the registry program if they request 112.14 to participate and meet the program's requirements; 112.15 (3) provide explanatory information and assistance to health care practitioners to 112.16 understand the nature of the therapeutic use of medical cannabis flower and medical 112.17 cannabinoid products within program requirements; 112.18 (4) make available to participating health care practitioners a certification form in which 112. i 9 a health care practitioner certifies that a patient has a qualifying medical condition; and 112.20 (5) supervise the participation of health care practitioners in the registry reporting system 112.21 in which health care practitioners report patient treatment and health records information 112.22 to the office in a manner that ensures stringent security and record keeping requirements 112.23 and that prevents the unauthorized release of private data on individuals as defined in section 112.24 13.02. 112.25 Subd. 2. Duties related to the registry program. The Division of Medical Cannabis 112.26 must: 112.27 (1) administer the registry program according to section 342.52; 112.28 (2) provide information to patients enrolled in the registry program on the existence of 112.29 federally approved clinical trials for the treatment of the patient's qualifying medical condition 112.30 with medical cannabis flower or medical cannabinoid products as an alternative to enrollment 112.31 in the registry program; Article 1 Sec. 54. 112